Sensus Healthcare (SRTS)
(Delayed Data from NSDQ)
$6.35 USD
-0.07 (-1.09%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $6.31 -0.04 (-0.63%) 7:58 PM ET
2-Buy of 5 2
C Value F Growth C Momentum D VGM
Brokerage Reports
0 items in cart
Sensus Healthcare, Inc. [SRTS]
Reports for Purchase
Showing records 81 - 100 ( 101 total )
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
4Q18 Recap - Strong Growth Should Continue in 2019
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Full-Year 2018 Financial Results Reported; Reiterate Buy and Raise Price Target to $13
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
We are transferring coverage, placing Under Review, and removing PT''s and estimates
Provider: Roth Capital Partners, Inc.
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
We are placing shares Under Review, and transferring coverage to due to the departure of the covering analyst
Provider: Roth Capital Partners, Inc.
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Positive Keloid Data; New Plastics Channel For SRT-100+; IORT 510k Looms
Provider: Roth Capital Partners, Inc.
Analyst: SOLOMON D
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
3Q18 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Unclassified
Financing Completed; Reiterate Buy and Lowering Price Target to $12
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sensus Healthcare, Inc.
Industry: Unclassified
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Sensus Healthcare, Inc.
Industry: Unclassified
Company: Sensus Healthcare, Inc.
Industry: Unclassified
Irradiating Away Skin Cancer Without Scars; Initiating With Buy and $14 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sensus Healthcare, Inc.
Industry: Unclassified
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Sensus Healthcare, Inc.
Industry: Unclassified
Company: Sensus Healthcare, Inc.
Industry: Unclassified
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.